Philippe Menasche, Paris
Sten Eirik Jacobsen, Stockholm
Eduard Batlle, Barcelona
Francesco Saverio Tedesco, London
Paul Riley, Oxford
Maria Pilar Alcolea, Cambridge
Francis Szele, Oxford
Ana Martin-Villalba, Heidelberg
Florian Merkle, Cambridge
Colin Goding, Oxford
J.P Martinez-Barbera, London
Siim Pauklin, Oxford
Alberto Baena Lopez, Oxford
Paola Bonfanti, London
Stuart Forbes, Edinburgh
Catherine Porcher, Oxford
Richard Wade-Martins, Oxford
Shukry Habib-King, London
One of the greatest challenges of the 21st century is disease associated with ageing. Cancer, neurodegeneration and heart disease are all major causes of death and have an enormous impact on quality of life.
Over recent years, a revolution in biology has meant that effective regenerative medicine, using stem cells to replace and repair damaged tissue is now on the horizon. Naturally occurring ‘immortal’ stem cells are present in all tissues of the body and act to replace loss of cells in tissues with rapid turnover, for example in the skin, blood or intestine, or to repair damage as in wound healing.
Harnessing the power of stem cells to regenerate damaged tissue in a range of diseases, or to generate tissue for organ repair following radical surgery, is a key goal. Yet how we can effectively manipulate stem cells for therapeutic use, and how we ensure their survival, for example after transplantation, remain major challenges.
The identification of physiological stem cells that regenerate tissues led to the discovery of stem-like cells in cancer. Cancer stem cells are resistant to therapy and provide a reservoir of cells able to regenerate tumours with their associated genetic heterogeneity, even many years after apparently successful therapy. Understanding the origins of cancer stem cells, how they are activated, and how they can be eradicated are key goals that must be met if we are to develop effective anti-cancer therapies.
The Oxford Stem Cell Institute (OSCI) was established in 2008 with funding from the Oxford Martin School and seeded multiple interdisciplinary collaborations and facilitated applications for substantial external funding. The OSCI comprises over 45 core and affiliated laboratories across Oxford and recognizes that the development of more effective stem cell and anti-cancer therapies would benefit from cross-disciplinary research that breaks the traditional taxonomic barriers boundaries between cancer, development and regenerative medicine.
Stem Cells UK - October 1st, 2019
Richard Gardner Lecture - November 1st, 2019 Prof Michele De Luca
Oxford Stem Cell Institute Annual Symposium - September 17th and 18th , 2019